Spina E - Search Results

1

Clinically relevant drug interactions between statins and antidepressants.

Palleria C, Roberti R, Iannone LF, Tallarico M, Barbieri MA, Vero A, Manti A, De Sarro G, Spina E, Russo E. Palleria C, et al. Among authors: spina e. J Clin Pharm Ther. 2020 Apr;45(2):227-239. doi: 10.1111/jcpt.13058. Epub 2019 Oct 6. J Clin Pharm Ther. 2020. PMID: 31587356 Review.

2

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Spina E, Pisani F, Perucca E. Spina E, et al. Clin Pharmacokinet. 1996 Sep;31(3):198-214. doi: 10.2165/00003088-199631030-00004. Clin Pharmacokinet. 1996. PMID: 8877250 Review.

3

Clinically significant drug interactions with antidepressants in the elderly.

Spina E, Scordo MG. Spina E, et al. Drugs Aging. 2002;19(4):299-320. doi: 10.2165/00002512-200219040-00004. Drugs Aging. 2002. PMID: 12038880 Review.

4

Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction.

Spina E, Avenoso A, Scordo MG, Ancione M, Madia A, Gatti G, Perucca E. Spina E, et al. J Clin Psychopharmacol. 2002 Aug;22(4):419-23. doi: 10.1097/00004714-200208000-00014. J Clin Psychopharmacol. 2002. PMID: 12172343

5

Metabolic drug interactions with new psychotropic agents.

Spina E, Scordo MG, D'Arrigo C. Spina E, et al. Fundam Clin Pharmacol. 2003 Oct;17(5):517-38. doi: 10.1046/j.1472-8206.2003.00193.x. Fundam Clin Pharmacol. 2003. PMID: 14703714 Review.

6

Metabolic drug interactions with newer antipsychotics: a comparative review.

Spina E, de Leon J. Spina E, et al. Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):4-22. doi: 10.1111/j.1742-7843.2007.00017.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 17214606 Free article. Review.

7

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C. Spina E, et al. Clin Ther. 2008 Jul;30(7):1206-27. doi: 10.1016/s0149-2918(08)80047-1. Clin Ther. 2008. PMID: 18691982 Review.

8

Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract.

Caraci F, Crupi R, Drago F, Spina E. Caraci F, et al. Among authors: spina e. Curr Drug Metab. 2011 Jul;12(6):570-7. doi: 10.2174/138920011795713706. Curr Drug Metab. 2011. PMID: 21395523 Review.

9

Clinically significant drug interactions with newer antidepressants.

Spina E, Trifirò G, Caraci F. Spina E, et al. CNS Drugs. 2012 Jan 1;26(1):39-67. doi: 10.2165/11594710-000000000-00000. CNS Drugs. 2012. PMID: 22171584 Review.

10

Clinically relevant drug interactions in anxiety disorders.

Muscatello MR, Spina E, Bandelow B, Baldwin DS. Muscatello MR, et al. Among authors: spina e. Hum Psychopharmacol. 2012 May;27(3):239-53. doi: 10.1002/hup.2217. Epub 2012 Feb 7. Hum Psychopharmacol. 2012. PMID: 22311403 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters